Are You Eligible for the Oncotype DX Cancer Test?
Oncotype DX is an influential genomic test within breast cancer management, offering a Recurrence Score to determine the necessity of adjuvant chemotherapy for estrogen receptor-positive and HER2-negative patients. It helps tailor treatments, guiding decisions between hormone therapy and chemotherapy based on individual genetic profiles, supported by clinical trials, thereby promoting personalized care and informed decision-making. […]
3 minute read